Intervention Review

Ibuprofen for Alzheimer's disease

  1. Naji Tabet1,*,
  2. Howard Feldman2

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 22 APR 2003

Assessed as up-to-date: 5 MAY 2008

DOI: 10.1002/14651858.CD004031


How to Cite

Tabet N, Feldman H. Ibuprofen for Alzheimer's disease. Cochrane Database of Systematic Reviews 2003, Issue 2. Art. No.: CD004031. DOI: 10.1002/14651858.CD004031.

Author Information

  1. 1

    University of Brighton, Postgraduate Medical School, Brighton, UK

  2. 2

    Vancouver Hospital and Health Sciences Center, UBC Division of Neurology, Vancouver, British Columbia, Canada

*Naji Tabet, Postgraduate Medical School, University of Brighton, Falmer, Brighton, BN1 9PH, UK. N.T.Tabet@bton.ac.uk.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 22 APR 2003

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yoo Kyeong Hwang, Ma Jinhua, Bo-Ryoung Choi, Chun-Ai Cui, Won Kyung Jeon, Hocheol Kim, Hahn Young Kim, Seol-Heui Han, Jung-Soo Han, Effects of Scutellaria baicalensis on chronic cerebral hypoperfusion-induced memory impairments and chronic lipopolysaccharide infusion-induced memory impairments, Journal of Ethnopharmacology, 2011, 137, 1, 681

    CrossRef

  2. 2
    Da-Qing Jin, Jin-Young Sung, Yoo Kyeong Hwang, Kyoung Ja Kwon, Seol-Heui Han, Sun Seek Min, Jung-Soo Han, Dexibuprofen (S(+)-isomer ibuprofen) reduces microglial activation and impairments of spatial working memory induced by chronic lipopolysaccharide infusion, Pharmacology Biochemistry and Behavior, 2008, 89, 3, 404

    CrossRef

  3. 3
    A.-S. Rigaud, F. Latour, H. Lenoir, C. Bayle, M.-L. Seux, O. Hanon, R. Péquignot, I. Cantegreil, E. Wenisch, F. Moulin, J. de Rotrou, Prise en charge thérapeutique de la démence, EMC - Traité de médecine AKOS, 2006, 1, 1, 1

    CrossRef

  4. 4
    A.-S. Rigaud, F. Latour, H. Lenoir, C. Bayle, M.-L. Seux, O. Hanon, R. Péquignot, I. Cantegreil, E. Wenisch, F. Moulin, J. de Rotrou, Prise en charge thérapeutique de la démence, EMC - Médecine, 2005, 2, 2, 145

    CrossRef

  5. 5
    A.-S. Rigaud, F. Latour, H. Lenoir, C. Bayle, M.-L. Seux, O. Hanon, R. Péquignot, I. Cantegreil, E. Wenisch, F. Moulin, J. de Rotrou, Tratamiento de la demencia, EMC - Tratado de Medicina, 2005, 9, 3, 1

    CrossRef

  6. 6
    Rebecca Davis, Mokhtar Gad El Kareem Nasr Isaac, Naji Tabet, Aspirin and anti-inflammatory drugs for Alzheimer's disease, The Cochrane Library,
  7. 7
    Naji Tabet, Howard Feldman, Ibuprofen for Alzheimer's disease, The Cochrane Library,
  8. 8
    Karen Rees, Rebecca Stowe, Smitaa Patel, Natalie Ives, Kieran Breen, Carl E Clarke, Yoav Ben-Shlomo, Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies, The Cochrane Library,
  9. 9
    Karen Rees, Rebecca Stowe, Smitaa Patel, Natalie Ives, Kieran Breen, Carl E Clarke, Yoav Ben-Shlomo, Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies, The Cochrane Library,